ZCM
ELGX

Zebra Capital Management’s Endologix Inc ELGX Stock Holding History

Zebra Capital Management’s Portfolio ELGX Stock Details ELGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-3,169
Closed -$23K – 497
2018
Q4 		$23K Sell
3,169
-500
-14% -$5.57K 0.01% 376
2018
Q3 		$70K Buy
+3,669
New +$131K 0.03% 414

Other funds holding ELGX

ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
SI
Stephens Inc Little Rock, Arkansas $7.99B AUM 21.6% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Zebra Capital Management's ELGX Position: Q1 2019 in Review

Zebra Capital Management sold out of Endologix Inc (ELGX) in Q1 2019, closing a stake of 3,169 shares — an estimated $23K sold.

Zebra Capital Management first reported a position in ELGX in Q3 2018 and held it in 2 quarters. The position peaked at $70K in Q3 2018. 63 funds tracked by Wall St. Rank hold ELGX as of Q1 2019.

  • Zebra Capital Management reported no remaining Endologix Inc position as of Q1 2019 after selling out during the quarter.
  • Zebra Capital Management sold 3,169 Endologix Inc shares in Q1 2019, an estimated $23K.
  • Zebra Capital Management first reported a position in Endologix Inc in Q3 2018 and held it in 2 quarters.
  • Zebra Capital Management's Endologix Inc position peaked at $70K in Q3 2018.
  • 63 funds tracked by Wall St. Rank held Endologix Inc as of Q1 2019.

Based on Zebra Capital Management's 13F filing for Q1 2019, filed 15 May 2019.